Skip to main content

Table 1 Clinical characteristics of AGCT in stage IC

From: Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?

 

All patients

NACG

ACG

p

N = 60

N = 28 (%)

N = 32 (%)

Age (median)

41.0

41.5

40.5

0.410

Tumor size (cm)

8

7

8.4

0.523

Serum Ca125(U / ml)

15.5

14.4

16.4

0.751

Menopause

   

0.744

Yes

14 (23.3)

6 (21.4)

8 (25.0)

 

No

46 (76.7)

22 (78.6)

24 (75.0)

 

FIGO stage (%)

   

0.944

IC1

34 (56.7)

16 (57.1)

18 (56.2)

 

IC2-IC3

26 (43.3)

12 (42.9)

14 (43.8)

 

Surgical procedure

   

0.605

Fertility surgery

30 (50.0)

15 (53.6)

15 (46.9)

 

Radical surgery

30 (50.0)

13 (46.4)

17 (53.1)

 

Staging operation

   

0.102

Yes

26 (43.3)

9 (32.1)

17 (53.1)

 

No

34 (56.7)

19 (67.9)

15 (46.9)

 

Lymphadenectomy

   

0.245

Yes

24 (40.0)

9 (32.1)

15 (46.9)

 

No

36 (60.0)

19 (67.9)

17 (53.1)

 

First operation at clinical

   

0.696

Our clinical

37 (61.7)

18 (64.3)

19 (59.4)

 

Outer

23 (38.3)

10 (35.7)

13 (40.6)

 
  1. AGCT: adult granulosa cell tumor; ACG: adjuvant chemotherapy group; NACG: no adjuvant chemotherapy group